Andrew Radin, Aria Pharmaceuticals CEO (Aria)
Andrew Radin orchestrates his AI discovery platform's pivot to R&D with a harmonious name change and eyes on the clinic
Andrew Radin was a straight A student. So when he stopped turning in assignments in Nigam Shah’s class at Stanford University, the professor knew something …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
